Another study revealed a significant increase in vWF activity and decreased ADAMTS-13 levels in COVID-19 patients, suggesting that impaired regulation of vWF and the reduced capacity of its cleavage by ADAMTS-13 could be indicative of an increased thrombosis risk (38). This evidence concerns the gene VWF and COVID-19.